Clearline Capital LP Lyra Therapeutics, Inc. Transaction History
Clearline Capital LP
- $3.49 Billion
- Q2 2024
A detailed history of Clearline Capital LP transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Clearline Capital LP holds 119,128 shares of LYRA stock, worth $29,782. This represents 0.0% of its overall portfolio holdings.
Number of Shares
119,128
Previous 119,128
-0.0%
Holding current value
$29,782
Previous $740,000
95.54%
% of portfolio
0.0%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding LYRA
# of Institutions
53Shares Held
31.6MCall Options Held
316KPut Options Held
600-
Perceptive Advisors LLC New York, NY12.8MShares$3.19 Million0.1% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.77MShares$1.19 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.83MShares$707,4940.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA2.78MShares$695,0650.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.73MShares$432,7280.0% of portfolio
About Lyra Therapeutics, Inc.
- Ticker LYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,826,400
- Market Cap $7.96M
- Description
- Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...